Patients with lymphomas are known to be at increased risk of developing second malignancies, especially acute myeloid leukaemia (Coleman et al., 1982; Tester et al., 1984) and, in the case of patients with Hodgkin's disease (HD), nonHodgkin's lymphomas (Jacquillat et al., 1984) . It has been suggested that the incidence of second malignancies in HD patients correlates with the level of treatment to which patients are exposed (Arseneau et al., 1972) , and, for those receiving very intensive chemotherapy and radiotherapy, the risk may increase by as much as 1,500 times (Coleman et al., 1982; Tester et al., 1984) . There is little evidence of an increased incidence of second malignancies in patients treated with radiotherapy alone leading some authors to postulate that the increase in risk is related to the use of chemotherapeutic agents, especially alkylating agents (Anonymous, 1985b) . These drugs are mutagenic and carcinogenic in laboratory systems and are also immunosuppressive (Schilsky & Erlichman, 1982) . Procarbazine, an important drug in the treatment of HD, is also highly carcinogenic in experimental systems (Schilsky & Erlichman, 1982) .
Patients with HD also suffer from an increased incidence of viral infections, including warts (Morison, 1975) , and this is believed to be due to alterations in immune function (Kumar & Penny, 1982) . Defects in cell-mediated immunity are seen much more commonly than defects in humoral immunity in untreated HD, and in HD patients in remission after treatment (Kumar & Penny, 1982; Bergmann et al., 1987) . Alterations in cell-mediated and humoral immunity tend to be seen only in advanced disease in non-Hodgkin's lymphomas (Kumar & Penny, 1982) .
Cell-mediated immunity is believed to be more important than humoral immunity in mediating immunosurveillance against tumours (Streilein, 1978) . Second malignancies may, therefore, develop in HD patients due to a primary defect in immunosurveillance rather than as a consequence of chemotherapy.
Although cervical neoplasia is reported to be increased in incidence in other immunosuppressed patients such as renal transplant recipients (Porreco et al., 1975) , the co-existence of this disease with lymphomas has previously been described only in the form of isolated case reports (ShokriTabibzadeh et al., 1981; Sillman et al., 1984) .
In this study we examined a defined group of patients suffering from HD or non-Hodgkin's lymphoma in an attempt to discover their relative risk of developing cervical neoplasia. We also looked for evidence of cervical human papillomavirus (HPV) infection in these patients, in view of the continuing debate concerning the role of this virus in cervical malignancy (Anonymous, 1985a) . There is some evidence that immunosuppression may lead to the malignant conversion of papillomavirus induced lesions in animals (Campo & Jarrett, 1987) and in man (Sillman et al., 1984; Rudlinger et al., 1986; Schneider et al., 1983 Table IV shows that the lymphoma patients with cervical koilocytosis without CIN were older, more likely to be parous and became sexually active rather later than the patients in whom no significant abnormality was detected. They also had had their lymphomas diagnosed for longer periods. Lymphoma patients with CIN, on the other hand, were younger, commenced sexual activity earlier and reported more sexual partners than did the patients in whom no abnormality was detected, although these differences were not statistically significant (0.1>P>0.05 by Mann-Whitney U test). Lymphomas had been diagnosed in these patients 
Discussion
We have demonstrated a significantly higher prevalence of CIN II and III in lymphoma patients than in a control group of women. Ideally each case should have been compared with two or three controls, matched with the case for known risk factors. However, colposcopic examination and biopsy is an invasive procedure and, when carried out on patients anaesthetised for dilatation and curettage or laparoscopic sterilisation, significantly increases the duration of the general anaesthetic. The recruitment and examination of the much larger number of controls necessary for this approach would have presented considerable practical problems and it was therefore decided that it was justifiable to compare lymphoma patients with available controls, matched only for age and oral contraceptive use. In fact the control patients reported on average more sexual partners and an earlier coitarche and were more likely to smoke than the lymphoma patients (see Table I ). A higher prevalence of CIN in the controls than in the lymphoma patients would be predicted on the basis of these known risk factors (La Vecchia, 1985; Winkelstein et al., 1984) . However, the reverse was found, that is a significantly higher prevalence of CIN II and III in lymphoma patients than in controls. This lends strong support to our contention that lymphoma patients are at increased risk of developing CIN, independent of known risk factors such as sexual behaviour and smoking. It is noteworthy that the lymphoma patients found to have CIN reported having had more sexual partners than did either the lymphoma patients without CIN or the normal controls (see Tables I and IV) . The malignant potential of CIN II and III is well defined with few cases regressing. The natural history of CIN I, on the other hand, is still controversial (Campion et al., 1986) as studies relying on cytology alone have tended to underestimate the severity of the initial lesion while those employing colposcopic punch biopsy have found this procedure to be curative in some cases, thus artificially increasing the 'regression' rate (Koss, 1978) . In view of this uncertainty, patients and controls with CIN I were separated from those with CIN II and III for the purpose of statistical analysis.
The increased prevalence of CIN in lymphoma patients is in agreement with the increase in other malignancies seen in these patients (Coleman et al., 1982; Tester et al., 1984) and may be due to immunosuppression. Five of the six lymphoma patients with CIN had received chemotherapy, which contributes to immunosuppression in these patients (Schilsky & Erlichman, 1982) . It should, however, be remembered that patients receiving chemotherapy tend to have more extensive disease so that the apparent association between CIN and chemotherapy may be due to the immunosuppressive effects of the disease rather than the effects of chemotherapy. We plan to explore this question further by studying breast cancer patients treated with alkylating agents in an attempt to separate the effects of these agents from the effects of the lymphoma.
It is interesting that no CIN was detected in nonHodgkin's lymphoma patients treated with chemotherapy. Less is known of the risk of second malignancies in nonHodgkin's lymphomas than in HD but the risk of acute myeloid leukaemia in patients treated with alkylating agents for non-Hodgkin's lymphoma appears to be similar to the risk seen in HD patients treated with these agents (PedersenBjergaard et al., 1985) . In this study there were only four patients with non-Hodgkin's lymphomas who received chemotherapy so that no firm conclusions can be drawn.
Of the six lymphoma patients with CIN, five had had cervical smears performed within the preceding 4 years, but only one of these smears was reported, on routine screening, to be abnormal. When smears were taken under optimal conditions at colposcopy and examined carefully three of six cases of CIN were still undetected. This is consistent with the published work of Giles et al. (1988) who studied 200 normal women and found that 22 (11%) had CIN; cervical cytology failed to detect seven (32%) of these cases.
The strong association between cervical HPV infection and cervical neoplasia is well recognised but whether the association is causal or casual is not known (Anonymous, 1985a) . In this study 52% of lymphoma patients had cytological and/or histological evidence of cervical HPV infection, alone or in association with CIN. This was significantly higher than the proportion of control patients with cervical HPV infection (see Table III ). However, it should be noted that the lymphoma patients with koilocytosis only, in the absence of CIN were, on average, 11 years older than those with CIN and had been sexually active for 6.6 years longer than CIN patients (see Table IV ). The 'koilocytosis only' patients had suffered from their lymphomas for longer than the CIN patients (i.e. 57.8 months before colposcopy versus 39 months). These data tend to argue against HPV infection being a premalignant condition and certainly demonstrate that, even in immunosuppressed women, neoplastic change does not inevitably follow. Other factors, including the degree of immunosuppression and the carcinogenic potential of chemotherapeutic agents given, as well as recognised risk factors such as early onset of sexual activity and multiple partners, are likely to be implicated.
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